Microglia are critical players in the neuroimmune system, and their involvement in Alzheimer’s disease (AD) pathogenesis is increasingly being recognized. However, whether microglia play a positive or negative role in AD remains largely controversial and the precise molecular targets for intervention are not well defined. This partly results from the opposing roles of microglia in AD pathology, and is mainly reflected in the microglia-neuron interaction. Microglia can prune synapses resulting in excessive synapse loss and neuronal dysfunction, but they can also promote synapse formation, enhancing neural network plasticity. Neuroimmune crosstalk accelerates microglial activation, which induces neuron death and enhances the microglial phagocytosis of β-amyloid to protect neurons. Moreover, microglia have dual opposing roles in developing the major pathological features in AD, such as amyloid deposition and blood-brain barrier permeability. This review summarizes the dual opposing role of microglia in AD from the perspective of the interaction between neurons and microglia. Additionally, current AD treatments targeting microglia and the advantages and disadvantages of developing microglia-targeted therapeutic strategies are discussed.
ADAPT-FS Research Group.2015. Follow-up evaluation of cognitive function in the randomized Alzheimer’s Disease Anti-inflammatory Prevention Trial and its follow-up study. Alzheimers Dement11:216–225.e1. https://doi.org/10.1016/j.jalz.2014.03.009
2.
AfaghACummingsBJCribbsDHCotmanCWTennerAJ. 1996. Localization and cell association of C1q in Alzheimer’s disease brain. Exp Neurol 138:22–32. https://doi.org/10.1006/exnr.1996.0043
3.
AudrainMHaure-MirandeJ-VWangMKimSHFanutzaTChakrabartyP, and others. 2019. Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau. Mol Psychiatry24:1383–97. https://doi.org/10.1038/s41380-018-0258-3
4.
BachstetterADMorgantiJMJernbergJSchlunkAMitchellSHBrewsterKW, and others. 2011. Fractalkine and CX3CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiol Aging32:2030–44. https://doi.org/10.1016/j.neurobiolaging.2009.11.022
5.
BadimonAStrasburgerHJAyataPChenXNairAIkegamiA, and others. 2020. Negative feedback control of neuronal activity by microglia. Nature586:417–23. https://doi.org/10.1038/s41586-020-2777-8
6.
BaidyaFBohraMDattaASarmahDShahBJagtapP, and others. 2021. Neuroimmune crosstalk and evolving pharmacotherapies in neurodegenerative diseases. Immunology162:160–78. https://doi.org/10.1111/imm.13264
7.
BaikSHKangSSonSMMook-JungI.2016. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer’s disease mouse model. Glia64:2274–90. https://doi.org/10.1002/glia.23074
8.
BishtKSharmaKTremblayM-È.2018. Chronic stress as a risk factor for Alzheimer’s disease: roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress. Neurobiol Stress9:9–21. https://doi.org/10.1016/j.ynstr.2018.05.003
9.
BishtKSharmaKPLecoursCGabriela SánchezMEl HajjHMiliorG, and others. 2016. Dark microglia: a new phenotype predominantly associated with pathological states. Glia64:826–39. https://doi.org/10.1002/glia.22966
10.
BonhamLWDesikanRSYokoyamaJSAlzheimer’s Disease Neuroimaging Initiative. 2016. The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease. Acta Neuropathol Commun4:65. https://doi.org/10.1186/s40478-016-0339-y
11.
BradtBMKolbWPCooperNR. 1998. Complement-dependent proinflammatory properties of the Alzheimer’s disease β-peptide. J Exp Med188:431–38. https://doi.org/10.1084/jem.188.3.431
12.
CarvalhoKFaivreEPietrowskiMJMarquesXGomez-MurciaVDeleauA, and others. 2019. Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor. Brain142:3636–54. https://doi.org/10.1093/brain/awz288
13.
ChakrabartyPLiACeballos-DiazCEddyJAFunkCCMooreB, and others. 2015. IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior. Neuron85:519–33. https://doi.org/10.1016/j.neuron.2014.11.020
14.
ChakrabartyPTianbaiLHerringACeballos-DiazCDasPGoldeTE. 2012. Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition. Mol Neurodegener7:36. https://doi.org/10.1186/1750-1326-7-36
15.
CondelloCYuanPSchainAGrutzendlerJ.2015. Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques. Nat Commun6:6176. https://doi.org/10.1038/ncomms7176
CserépCPósfaiBDénesÁ.2021. Shaping neuronal fate: functional heterogeneity of direct microglia-neuron interactions. Neuron109:222–40. https://doi.org/10.1016/j.neuron.2020.11.007
18.
CserépCPósfaiBLénártNFeketeRLászlóZILeleZ, and others. 2020. Microglia monitor and protect neuronal function through specialized somatic purinergic junctions. Science367:528–37. https://doi.org/10.1126/science.aax6752
19.
CzirrECastelloNAMosherKICastellanoJMHinksonIVLucinKM, and others. 2017. Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity. J Exp Med214:1081–92. https://doi.org/10.1084/jem.20162011
20.
DagherNNNajafiARKayalaKMNElmoreMRPWhiteTEMedeirosR, and others. 2015. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice. J Neuroinflammation12:139. https://doi.org/10.1186/s12974-015-0366-9
21.
DanielsMJDRivers-AutyJSchillingTSpencerNGWatremezWFasolinoV, and others. 2016. Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer’s disease in rodent models. Nat Commun7:12504. https://doi.org/10.1038/ncomms12504
22.
DaviesDSMaJJegatheesTGoldsburyC.2017. Microglia show altered morphology and reduced arborization in human brain during aging and Alzheimer’s disease. Brain Pathol27:795–808. https://doi.org/10.1111/bpa.12456
23.
de WildeMCOverkCRSijbenJWMasliahE.2016. Meta-analysis of synaptic pathology in Alzheimer’s disease reveals selective molecular vesicular machinery vulnerability. Alzheimers Dement12:633–44. https://doi.org/10.1016/j.jalz.2015.12.005
24.
DelpechJ-CHerronSBotrosMBIkezuT.2019. Neuroimmune crosstalk through extracellular vesicles in health and disease. Trends Neurosci42:361–72. https://doi.org/10.1016/j.tins.2019.02.007
25.
DempseyCRubio AraizABrysonKJFinucaneOLarkinCMillsEL, and others. 2017. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice. Brain Behav Immun61:306–16. https://doi.org/10.1016/j.bbi.2016.12.014
26.
DingXWangJHuangMChenZLiuJZhangQ, and others. 2021. Loss of microglial SIRPα promotes synaptic pruning in preclinical models of neurodegeneration. Nat Commun12:2030. https://doi.org/10.1038/s41467-021-22301-1
27.
El HajjHSavageJCBishtKParentMVallièresLRivestS, and others. 2019. Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology. J Neuroinflammation16:87. https://doi.org/10.1186/s12974-019-1473-9
28.
El KhouryJToftMHickmanSEMeansTKTeradaKGeulaC, and others. 2007. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med13, 432–8. https://doi.org/10.1038/nm1555
29.
EllwangerDCWangSBrioschiSShaoZGreenLCaseR, and others. 2021. Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci U S A 118:e2017742118. https://doi.org/10.1073/pnas.2017742118
30.
FengJWangJ-XDuY-HLiuYZhangWChenJ-F, and others. 2018. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice. CNS Neurosci Ther24:1207–18. https://doi.org/10.1111/cns.12983
31.
FengY-STanZ-XWuL-YDongFZhangF.2020. The involvement of NLRP3 inflammasome in the treatment of Alzheimer’s disease. Ageing Res Rev64:101192. https://doi.org/10.1016/j.arr.2020.101192
32.
FourgeaudLTravésPGTufailYLeal-BaileyHLewEDBurrolaPG, and others. 2016. TAM receptors regulate multiple features of microglial physiology. Nature532:240–4. https://doi.org/10.1038/nature17630
33.
Franco-BocanegraDKGeorgeBLauLCHolmesCNicollJARBocheD.2019a. Microglial motility in Alzheimer’s disease and after Aβ42 immunotherapy: a human post-mortem study. Acta Neuropathol Commun7:174. https://doi.org/10.1186/s40478-019-0828-x
34.
Franco-BocanegraDKMcAuleyCNicollJARBocheD.2019b. Molecular mechanisms of microglial motility: changes in ageing and Alzheimer’s disease. Cells8:639. https://doi.org/10.3390/cells8060639
35.
FrikerLLScheiblichHHochheiserIVBrinkschulteRRiedelDLatzE, and others. 2020. β-Amyloid clustering around ASC fibrils boosts its toxicity in microglia. Cell Rep30:3743–3754.e6. https://doi.org/10.1016/j.celrep.2020.02.025
36.
FuWVukojevicVPatelASoudyRMacTavishDWestawayD, and others. 2017. Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation. J Neuroinflammation14:199. https://doi.org/10.1186/s12974-017-0972-9
37.
GeirsdottirLDavidEKeren-ShaulHWeinerABohlenSCNeuberJ, and others. 2019. Cross-species single-cell analysis reveals divergence of the primate microglia program. Cell179:1609–22.e16. https://doi.org/10.1016/j.cell.2019.11.010
38.
GerritsEBrouwerNKooistraSMWoodburyMEVermeirenYLambourneM, and others. 2021. Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease. Acta Neuropathol141:681–96. https://doi.org/10.1007/s00401-021-02263-w
39.
GlennerGGWongCW. 1984. Alzheimer’s disease and Down’s syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun122:1131–5. https://doi.org/10.1016/0006-291x(84)91209-9
40.
GouwensLKIsmailMSRogersVAZellerNTGarradECAmtasharFS, and others. 2018. Aβ42 protofibrils interact with and are trafficked through microglial-derived microvesicles. ACS Chem Neurosci9:1416–25. https://doi.org/10.1021/acschemneuro.8b00029
41.
GriciucAFedericoANNatasanJForteAMMcGintyDNguyenH, and others. 2020. Gene therapy for Alzheimer’s disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation. Hum Mol Genet29:2920–35. https://doi.org/10.1093/hmg/ddaa179
42.
GriciucAPatelSFedericoANChoiSHInnesBJOramMK, and others. 2019. TREM2 acts downstream of CD33 in modulating microglial pathology in Alzheimer’s disease. Neuron103:820-35.e7. https://doi.org/10.1016/j.neuron.2019.06.010
43.
GrubmanAChooXYChewGOuyangJFSunGCroftNP, and others. 2021. Transcriptional signature in microglia associated with Aβ plaque phagocytosis. Nat Commun12:3015. https://doi.org/10.1038/s41467-021-23111-1
44.
Guillot-SestierM-VDotyKRGateDRodriguezJLeungBPRezai-ZadehK, and others. 2015. Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron85:534–48. https://doi.org/10.1016/j.neuron.2014.12.068
45.
GuttikondaSRSikkemaLTchieuJSauratNWalshRMHarschnitzO, and others. 2021. Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer’s disease. Nat Neurosci24:343–54. https://doi.org/10.1038/s41593-020-00796-z
46.
HalleAHornungVPetzoldGCStewartCRMonksBGReinheckelT, and others. 2008. The NALP3 inflammasome is involved in the innate immune response to amyloid-β. Nat Immunol9:857–65. https://doi.org/10.1038/ni.1636
47.
HaruwakaKIkegamiATachibanaYOhnoNKonishiHHashimotoA, and others. 2019. Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat Commun10:5816. https://doi.org/10.1038/s41467-019-13812-z
48.
Haure-MirandeJ-VAudrainMFanutzaTKimSHKleinWLGlabeC, and others. 2017. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer’s pathology. Acta Neuropathol134:769–88. https://doi.org/10.1007/s00401-017-1737-3
49.
Haure-MirandeJ-VWangMAudrainMFanutzaTKimSHHejaS, and others. 2019. Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden. Mol Psychiatry24:431–46. https://doi.org/10.1038/s41380-018-0255-6
50.
HenekaMTNadrignyFRegenTMartinez-HernandezADumitrescu-OzimekLTerwelD, and others. 2010. Locus ceruleus controls Alzheimer’s disease pathology by modulating microglial functions through norepinephrine. Proc Natl Acad Sci U S A107:6058–63. https://doi.org/10.1073/pnas.0909586107
51.
HenstridgeCMHymanBTSpires-JonesTL. 2019. Beyond the neuron–cellular interactions early in Alzheimer disease pathogenesis. Nat Rev Neurosci20:94–108. https://doi.org/10.1038/s41583-018-0113-1
HickmanSEAllisonEKColemanUKingery-GallagherNDEl KhouryJ.2019. Heterozygous CX3CR1 deficiency in microglia restores neuronal β-amyloid clearance pathways and slows progression of Alzheimer’s like-disease in PS1-APP mice. Front Immunol10:2780. https://doi.org/10.3389/fimmu.2019.02780
54.
HongSBeja-GlasserVFNfonoyimBMFrouinALiSRamakrishnanS, and others. 2016. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science352:712–6. https://doi.org/10.1126/science.aad8373
55.
HoshikoMArnouxIAvignoneEYamamotoNAudinatE.2012. Deficiency of the microglial receptor CX3CR1 impairs postnatal functional development of thalamocortical synapses in the barrel cortex. J Neurosci32:15106–11. https://doi.org/10.1523/JNEUROSCI.1167-12.2012
56.
HoutmanJFreitagKGimberNSchmoranzerJHeppnerFLJendrachM.2019. Beclin1-driven autophagy modulates the inflammatory response of microglia via NLRP 3. EMBO J 38:e99430. https://doi.org/10.15252/embj.201899430
57.
HuangYHapponenKEBurrolaPGO’ConnorCHahNHuangL, and others. 2021. Microglia use TAM receptors to detect and engulf amyloid β plaques. Nat Immunol22:586–94. https://doi.org/10.1038/s41590-021-00913-5
58.
IaccarinoHFSingerACMartorellAJRudenkoAGaoFGillinghamTZ, and others. 2016. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature540:230–5. https://doi.org/10.1038/nature20587
59.
IkezuSYehHDelpechJ-CWoodburyMEVan EnooAARuanZ, and others. 2021. Inhibition of colony stimulating factor 1 receptor corrects maternal inflammation-induced microglial and synaptic dysfunction and behavioral abnormalities. Mol Psychiatry26:1808–31. https://doi.org/10.1038/s41380-020-0671-2
60.
IllesPVerkhratskyATangY.2021. Surveilling microglia dampens neuronal activity: operation of a purinergically mediated negative feedback mechanism. Signal Transduct Target Ther6:160. https://doi.org/10.1038/s41392-021-00586-4
61.
JassamYNIzzySWhalenMMcGavernDBEl KhouryJ.2017. Neuroimmunology of traumatic brain injury: time for a paradigm shift. Neuron95:1246–65. https://doi.org/10.1016/j.neuron.2017.07.010
62.
JaturapatpornDIsaacMGEKNMcCleeryJTabetN.2012. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer’s disease. Cochrane Database Syst Rev 2:CD006378. https://doi.org/10.1002/14651858.CD006378.pub2
63.
JhaMKJoMKimJHSukK.2019. Microglia-astrocyte crosstalk: an intimate molecular conversation. Neuroscientist25:227–40. http://doi.10.1177/1073858418783959
64.
JoshiPTurolaERuizABergamiALiberaDDBenussiL, and others. 2014. Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles. Cell Death Differ21:582–93. https://doi.org/10.1038/cdd.2013.180
65.
KaindlAMDegosVPeineauSGouadonEChhorVLoronG, and others. 2012. Activation of microglial N-methyl-d-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Ann Neurol72:536–49. https://doi.org/10.1002/ana.23626
66.
Keren-ShaulHSpinradAWeinerAMatcovitch-NatanODvir-SzternfeldRUllandTK, and others. 2017. A unique microglia type associated with restricting development of Alzheimer’s disease. Cell169:1276–1290.e17. https://doi.org/10.1016/j.cell.2017.05.018
67.
KimH-JChoM-HShimWHKimJKJeonE-YKimD-H, and others. 2017. Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects. Mol Psychiatry22:1576–84. https://doi.org/10.1038/mp.2016.103
68.
KimNDoJJuIGJeonSHLeeJKOhMS. 2020. Picrorhiza kurroa prevents memory deficits by inhibiting NLRP3 inflammasome activation and BACE1 expression in 5xFAD mice. Neurotherapeutics17:189–99. https://doi.org/10.1007/s13311-019-00792-7
69.
KoffieRMHashimotoTTaiH-CKayKRSerrano-PozoAJoynerD, and others. 2012. Apolipoprotein E4 effects in Alzheimer’s disease are mediated by synaptotoxic oligomeric amyloid-β. Brain135:2155–68. https://doi.org/10.1093/brain/aws127
70.
KrabbeGHalleAMatyashVRinnenthalJLEomGDBernhardtU, and others 2013. Functional impairment of microglia coincides with beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One8:e60921. https://doi.org/10.1371/journal.pone.0060921
71.
KrasemannSMadoreCCialicRBaufeldCCalcagnoNEl FatimyR, and others. 2017. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity47:566–581.e9. https://doi.org/10.1016/j.immuni.2017.08.008
72.
KyrargyriVMadryCRifatAArancibia-CarcamoILJonesSPChanVTT, and others. 2020. P2Y13 receptors regulate microglial morphology, surveillance, and resting levels of interleukin 1β release. Glia68:328–44. https://doi.org/10.1002/glia.23719
73.
LaiMKPTanMGKKirvellSHobbsCLeeJEsiriMM, and others. 2008. Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer’s disease neuropathology. J Neural Transm (Vienna)115:1165–72. https://doi.org/10.1007/s00702-008-0067-y
74.
LauS-FChenCFuW-YQuJYCheungTHFuAKY, and others. 2020. IL-33-PU.1 transcriptome reprogramming drives functional state transition and clearance activity of microglia in Alzheimer’s disease. Cell Rep31:107530. https://doi.org/10.1016/j.celrep.2020.107530
75.
LehrmanEKWiltonDKLitvinaEYWelshCAChangSTFrouinA, and others. 2018. CD47 protects synapses from excess microglia-mediated pruning during development. Neuron100:120–134.e6. https://doi.org/10.1016/j.neuron.2018.09.017
76.
LeiFCuiNZhouCChodoshJVavvasDGPaschalisEI. 2020. CSF1R inhibition by a small-molecule inhibitor is not microglia specific; affecting hematopoiesis and the function of macrophages. Proc Natl Acad Sci U S A117:23336–8. https://doi.org/10.1073/pnas.1922788117
77.
LengFEdisonP.2021. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?Nat Rev Neurol17:157–72. https://doi.org/10.1038/s41582-020-00435-y
78.
LevitesYFunkCWangXChakrabartyPMcFarlandKNBramblettB, and others. 2021. Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapy. Mol Neurodegener16:32. https://doi.org/10.1186/s13024-021-00453-4
79.
LiTChiouBGilmanCKLuoRKoshiTYuD, and others. 2020. A splicing isoform of GPR56 mediates microglial synaptic refinement via phosphatidylserine binding. EMBO J39:e104136. https://doi.org/10.15252/embj.2019104136
80.
LiYDuXLiuCWenZDuJ.2012. Reciprocal regulation between resting microglial dynamics and neuronal activity in vivo. Dev Cell23:1189–202. https://doi.org/10.1016/j.devcel.2012.10.027
81.
LiddelowSAGuttenplanKAClarkeLEBennettFCBohlenCJSchirmerL, and others. 2017. Neurotoxic reactive astrocytes are induced by activated microglia. Nature541:481–7. https://doi.org/10.1038/nature21029
82.
LiebnerSDijkhuizenRMReissYPlateKHAgalliuDConstantinG.2018. Functional morphology of the blood-brain barrier in health and disease. Acta Neuropathol135:311–36. https://doi.org/10.1007/s00401-018-1815-1
83.
LiuYUYingYLiYEyoUBChenTZhengJ, and others. 2019. Neuronal network activity controls microglial process surveillance in awake mice via norepinephrine signaling. Nat Neurosci22:1771–81. https://doi.org/10.1038/s41593-019-0511-3
84.
LiuZCondelloCSchainAHarbRGrutzendlerJ.2010. CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis. J Neurosci30:17091–101. https://doi.org/10.1523/JNEUROSCI.4403-10.2010
85.
LouNTakanoTPeiYXavierALGoldmanSANedergaardM.2016. Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier. Proc Natl Acad Sci U S A113:1074–9. https://doi.org/10.1073/pnas.1520398113
86.
MadoreCLeyrolleQMorelLRossittoMGreenhalghADDelpechJC, and others. 2020. Essential omega-3 fatty acids tune microglial phagocytosis of synaptic elements in the mouse developing brain. Nat Commun11:6133. https://doi.org/10.1038/s41467-020-19861-z
87.
MadryCKyrargyriVArancibia-CárcamoILJolivetRKohsakaSBryanRM, and others. 2018. Microglial ramification, surveillance, and interleukin-1β release are regulated by the two-pore domain K+ channel THIK-1. Neuron97:299–312.e6. https://doi.org/10.1016/j.neuron.2017.12.002
88.
MancusoRFryattGClealMObstJPipiEMonzón-SandovalJ, and others. 2019. CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice. Brain142:3243–64. https://doi.org/10.1093/brain/awz241
89.
MartinEAmarMDalleCYoussefIBoucherCLe DuigouC, and others. 2019. New role of P2X7 receptor in an Alzheimer’s disease mouse model. Mol Psychiatry24:108–25. https://doi.org/10.1038/s41380-018-0108-3
90.
MartinezFOGordonSLocatiMMantovaniA.2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol177:7303–11. https://doi.org/10.4049/jimmunol.177.10.7303
91.
MartorellAJPaulsonALSukH-JAbdurrobFDrummondGTGuanW, and others. 2019. Multi-sensory gamma stimulation ameliorates Alzheimer’s-associated pathology and improves cognition. Cell177:256–271.e22. https://doi.org/10.1016/j.cell.2019.02.014
92.
MathysHAdaikkanCGaoFYoungJZManetEHembergM, and others. 2017. Temporal tracking of microglia activation in neurodegeneration at single-cell resolution. Cell Rep21:366–80. https://doi.org/10.1016/j.celrep.2017.09.039
93.
MazaheriFSnaideroNKleinbergerGMadoreCDariaAWernerG, and others. 2017. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury. EMBO Rep18:1186–98. https://doi.org/10.15252/embr.201743922
MerliniMRafalskiVARios CoronadoPEGillTMEllismanMMuthukumarG, and others. 2019. Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer’s disease model. Neuron101:1099–1108.e6. https://doi.org/10.1016/j.neuron.2019.01.014
96.
MoMEyoUBXieMPengJBoscoDBUmpierreAD, and others. 2019. Microglial P2Y12 receptor regulates seizure-induced neurogenesis and immature neuronal projections. J Neurosci39:9453–64. https://doi.org/10.1523/JNEUROSCI.0487-19.2019
NguyenATWangKHuGWangXMiaoZAzevedoJA, and others. 2020. APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer’s disease. Acta Neuropathol140:477–93. https://doi.org/10.1007/s00401-020-02200-3
100.
Olmos-AlonsoASchettersSTTSriSAskewKMancusoRVargas-CaballeroM, and others. 2016. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology. Brain139:891–907. https://doi.org/10.1093/brain/awv379
101.
PaasilaPJDaviesDSKrilJJGoldsburyCSutherlandGT. 2019. The relationship between the morphological subtypes of microglia and Alzheimer’s disease neuropathology. Brain Pathol29:726–40. https://doi.org/10.1111/bpa.12717
102.
PaolicelliRCJawaidAHenstridgeCMValeriAMerliniMRobinsonJL, and others. 2017. TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss. Neuron95:297–308.e6. https://doi.org/10.1016/j.neuron.2017.05.037
103.
PeferoenLKippMValkPNoortJMAmorS.2014. Oligodendrocyte-microglia cross-talk in the central nervous system. Immunology141:302–13. https://doi.org/10.1111/imm.12163
104.
PerssonA-KEstacionMAhnHLiuSStamboulian-PlatelSWaxmanSG, and others. 2014. Contribution of sodium channels to lamellipodial protrusion and Rac1 and ERK1/2 activation in ATP-stimulated microglia: sodium channels and lamellipodial protrusion. Glia62:2080–95. https://doi.org/10.1002/glia.22728
105.
PiersTMEastEVillegas-LlerenaCSevastouIGMatarinMHardyJ, and others. 2018. Soluble fibrinogen triggers non-cell autonomous ER stress-mediated microglial-induced neurotoxicity. Front Cell Neurosci12:404. https://doi.org/10.3389/fncel.2018.00404
106.
PonsVLévesquePPlanteM-MRivestS.2021. Conditional genetic deletion of CSF1 receptor in microglia ameliorates the physiopathology of Alzheimer’s disease. Alzheimers Res Ther13:8. https://doi.org/10.1186/s13195-020-00747-7
107.
PradaIGabrielliMTurolaEIorioAD’ArrigoGParolisiR, and others. 2018. Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterations. Acta Neuropathol135:529–50. https://doi.org/10.1007/s00401-017-1803-x
RelkinNRThomasRGRissmanRABrewerJBRafiiMSvan DyckCH, and others for the Alzheimer’s Disease Cooperative Study. 2017. A phase 3 trial of IV immunoglobulin for Alzheimer disease. Neurology88:1768–75. https://doi.org/10.1212/WNL.0000000000003904
111.
RogersJTMorgantiJMBachstetterADHudsonCEPetersMMGrimmigBA, and others. 2011. CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J Neurosci31:16241–50. https://doi.org/10.1523/JNEUROSCI.3667-11.2011
112.
RonaldsonPTDavisTP. 2020. Regulation of blood-brain barrier integrity by microglia in health and disease: a therapeutic opportunity. J Cereb Blood Flow Metab40(1_suppl):S6–S24. https://doi.org/10.1177/0271678X20951995
113.
RosinJMVoraSRKurraschDM.2018. Depletion of embryonic microglia using the CSF1R inhibitor PLX5622 has adverse sex-specific effects on mice, including accelerated weight gain, hyperactivity and anxiolytic-like behaviour. Brain Behav Immun73:682–97. https://doi.org/10.1016/j.bbi.2018.07.023
114.
RoyERWangBWanY-WChiuGColeAYinZ, and others. 2020. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J Clin Invest130:1912–30. https://doi.org/10.1172/JCI133737
115.
Sala FrigerioCWolfsLFattorelliNThruppNVoytyukISchmidtI, and others. 2019. The major risk factors for Alzheimer’s disease: age, sex, and genes modulate the microglia response to Aβ plaques. Cell Rep27:1293-306.e6. https://doi.org/10.1016/j.celrep.2019.03.099
116.
SchartzNDTennerAJ. 2020. The good, the bad, and the opportunities of the complement system in neurodegenerative disease. J Neuroinflammation17:354. https://doi.org/10.1186/s12974-020-02024-8
117.
ScheiblichHTromblyMRamirezAHenekaMT.2020. Neuroimmune connections in aging and neurodegenerative diseases. Trends Immunol41:300–12. https://doi.org/10.1016/j.it.2020.02.002
118.
SchlepckowKMonroeKMKleinbergerGCantuti-CastelvetriLParhizkarSXiaD, and others. 2020. Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region. EMBO Mol Med 12:e11227. https://doi.org/10.15252/emmm.201911227
119.
Scott-HewittNPerrucciFMoriniRErreniMMahoneyMWitkowskaA, and others. 2020. Local externalization of phosphatidylserine mediates developmental synaptic pruning by microglia. EMBO J 39:e105380. https://doi.org/10.15252/embj.2020105380
120.
ShiQChowdhurySMaRLeKXHongSCaldaroneBJ, and others. 2017. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice. Sci Transl Med9(392):eaaf6295. https://doi.org/10.1126/scitranslmed.aaf6295
121.
SierraAEncinasJMDeuderoJJPChanceyJHEnikolopovGOverstreet-WadicheLS, and others. 2010. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell7:483–95. https://doi.org/10.1016/j.stem.2010.08.014
122.
Solé-DomènechSRojasAVMaisuradzeGGScheragaHALobelPMaxfieldFR. 2018. Lysosomal enzyme tripeptidyl peptidase 1 destabilizes fibrillar Aβ by multiple endoproteolytic cleavages within the β-sheet domain. Proc Natl Acad Sci U S A115:1493–8. https://doi.org/10.1073/pnas.1719808115
SosnaJPhilippSAlbayRReyes-RuizJMBaglietto-VargasDLaFerlaFM, and others. 2018. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer’s disease. Mol Neurodegener13:11. https://doi.org/10.1186/s13024-018-0244-x
SpangenbergESeversonPLHohsfieldLACrapserJZhangJBurtonEA, and others. 2019. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model. Nat Commun10:3758. https://doi.org/10.1038/s41467-019-11674-z
127.
SpangenbergEELeeRJNajafiARRiceRAElmoreMRPBlurton-JonesM, and others. 2016. Eliminating microglia in Alzheimer’s mice prevents neuronal loss without modulating amyloid-β pathology. Brain139:1265–81. https://doi.org/10.1093/brain/aww016
128.
SrinivasanKFriedmanBAEtxeberriaAHuntleyMAvan der BrugMPForemanO, and others. 2020. Alzheimer’s patient microglia exhibit enhanced aging and unique transcriptional activation. Cell Rep31:107843. https://doi.org/10.1016/j.celrep.2020.107843
129.
StowellRDSipeGODawesRPBatchelorHNLordyKAWhitelawBS, and others. 2019. Noradrenergic signaling in the wakeful state inhibits microglial surveillance and synaptic plasticity in the mouse visual cortex. Nat Neurosci22:1782–92. https://doi.org/10.1038/s41593-019-0514-0
130.
StreitWJBraakHXueQ-SBechmannI.2009. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease. Acta Neuropathol118:475–85. https://doi.org/10.1007/s00401-009-0556-6
131.
SubramanianJSavageJCTremblayM-È. 2020. Synaptic loss in Alzheimer’s disease: mechanistic insights provided by two-photon in vivo imaging of transgenic mouse models. Front Cell Neurosci14:592607. https://doi.org/10.3389/fncel.2020.592607
132.
SweeneyMDSagareAPZlokovicBV. 2018. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol14:133–50. https://doi.org/10.1038/nrneurol.2017.188
133.
SzalayGMartineczBLénártNKörnyeiZOrsolitsBJudákL, and others. 2016. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. Nat Commun7:11499. https://doi.org/10.1038/ncomms11499
UlrichJDUllandTKMahanTENyströmSNilssonKPSongWM, and others. 2018. ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med215:1047–58. https://doi.org/10.1084/jem.20171265
137.
VargaDPMenyhártÁPósfaiBCsászárELénártNCserépC, and others. 2020. Microglia alter the threshold of spreading depolarization and related potassium uptake in the mouse brain. J Cereb Blood Flow Metab40(1_suppl):S67–S80. https://doi.org/10.1177/0271678X19900097
VenegasCKumarSFranklinBSDierkesTBrinkschulteRTejeraD, and others. 2017. Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease. Nature552:355–61. https://doi.org/10.1038/nature25158
140.
VicidominiCGuoNSahayA.2020. Communication, cross talk, and signal integration in the adult hippocampal neurogenic niche. Neuron105:220–35. https://doi.org/10.1016/j.neuron.2019.11.029
141.
WangCYeoSHaasMAGuanJ-L.2017. Autophagy gene FIP200 in neural progenitors non–cell autonomously controls differentiation by regulating microglia. J Cell Biol216:2581–96. https://doi.org/10.1083/jcb.201609093
142.
WangCYueHHuZShenYMaJLiJ, and others. 2020a. Microglia mediate forgetting via complement-dependent synaptic elimination. Science367:688–94. https://doi.org/10.1126/science.aaz2288
143.
WangSMustafaMYuedeCMSalazarSVKongPLongH, and others. 2020b. Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer’s disease model. J Exp Med217:e20200785. https://doi.org/10.1084/jem.20200785
144.
WhiteCSLawrenceCBBroughDRivers-AutyJ.2017. Inflammasomes as therapeutic targets for Alzheimer’s disease: inflammasomes as therapeutic targets. Brain Pathol27:223–34. https://doi.org/10.1111/bpa.12478
WuA-GZhouX-GQiaoGYuLTangYYanL, and others. 2021. Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases. Ageing Res Rev65:101202. https://doi.org/10.1016/j.arr.2020.101202
147.
YinCAckermannSMaZMohantaSKZhangCLiY, and others. 2019. ApoE attenuates unresolvable inflammation by complex formation with activated C1q. Nat Med25:496–506. https://doi.org/10.1038/s41591-018-0336-8
148.
YinJZhaoFChojnackiJEFulpJKleinWLZhangS, and others. 2018. NLRP3 inflammasome inhibitor ameliorates amyloid pathology in a mouse model of Alzheimer’s disease. Mol Neurobiol55:1977–87. https://doi.org/10.1007/s12035-017-0467-9
149.
YuanPCondelloCKeeneCDWangYBirdTDPaulSM, and others. 2016. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron90:724–39. https://doi.org/10.1016/j.neuron.2016.05.003
150.
ZhanYPaolicelliRCSforazziniFWeinhardLBolascoGPaganiF, and others. 2014. Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat Neurosci17:400–6. https://doi.org/10.1038/nn.3641
151.
ZhangJRongPZhangLHeHZhouTFanY, and others. 2021. IL4-driven microglia modulate stress resilience through BDNF-dependent neurogenesis. Sci Adv 7:eabb9888.https://doi.org/10.1126/sciadv.abb9888
152.
ZhaoJFuYYamazakiYRenYDavisMDLiuC-C, and others. 2020. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids. Nat Commun11:5540. https://doi.org/10.1038/s41467-020-19264-0
153.
ZhaoYWuXLiXJiangL-LGuiXLiuY, and others. 2018. TREM2 is a receptor for β-amyloid that mediates microglial function. Neuron97:1023–1031.e7. https://doi.org/10.1016/j.neuron.2018.01.031
154.
ZhongLXuYZhuoRWangTWangKHuangR, and others. 2019. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model. Nat Commun10:1365. https://doi.org/10.1038/s41467-019-09118-9
155.
ZhouYSongWMAndheyPSSwainALevyTMillerKR, and others. 2020. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease. Nat Med26:131–42. https://doi.org/10.1038/s41591-019-0695-9
